Thursday , November 26 2020
Home / Michel Accad, Anish Koka /Can We Trust Generic Drugs? The Ranbaxy Whistleblower Narrates the Pharma Scandal of the Century

Can We Trust Generic Drugs? The Ranbaxy Whistleblower Narrates the Pharma Scandal of the Century

Summary:
Generic drugs represent 90% of the pharmaceutical market. Their use has been encouraged through decades of favorable legislation and subsidies, with authorities claiming they are as safe and effective as brand name drugs. Yet generic preparations tainted with impurities are being reported with increasing frequency. What should doctors and the public know about generic drug ...

Topics:
Michel Accad, Anish Koka considers the following as important:

This could be interesting, too:

David Stockman writes The Mother-Of-All-Puts

Mark Hendrickson writes Giving Thanks to Society’s Economic Benefactors

Ryan McMaken writes Was the Election Free and Fair? The American Foreign Policy Establishment Doesn’t Care.

Frank Shostak writes Why the IMF Is Wrong about Liquidity Traps

Generic drugs represent 90% of the pharmaceutical market. Their use has been encouraged through decades of favorable legislation and subsidies, with authorities claiming they are as safe and effective as brand name drugs. Yet generic preparations tainted with impurities are being reported with increasing frequency. What should doctors and the public know about generic drug manufacture? Our guest, Dinesh Thakur, is the chemist who was at the center of the most important scandal to rock the global pharmaceutical industry in decades.

Leave a Reply

Your email address will not be published. Required fields are marked *